papaverine and alpha-aminopyridine

papaverine has been researched along with alpha-aminopyridine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Boyd, DK; Evans, DB; Quade, M; Schenden, JA; Weishaar, RE1
Bass, CR; Meaney, DF; Morales, FN; Morrison, B; Vogel, EW1
Ansari, MN; Rehman, NU; Samad, A1

Other Studies

3 other study(ies) available for papaverine and alpha-aminopyridine

ArticleYear
Studies aimed at elucidating the mechanism of action of CI-914, a new cardiotonic agent.
    European journal of pharmacology, 1985, Dec-17, Volume: 119, Issue:3

    Topics: Adenosine Triphosphate; Adenylyl Cyclases; Aminopyridines; Amrinone; Animals; Calcium; Cardiotonic Agents; Cyclic AMP; Dogs; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Mitochondria, Heart; Myocardial Contraction; Myocardium; Ouabain; Papaverine; Papillary Muscles; Phosphodiesterase Inhibitors; Pyridazines; Rabbits; Sarcoplasmic Reticulum; Sodium-Potassium-Exchanging ATPase; Theophylline

1985
Phosphodiesterase-4 inhibition restored hippocampal long term potentiation after primary blast.
    Experimental neurology, 2017, Volume: 293

    Topics: Aminopyridines; Animals; Animals, Newborn; Benzamides; Blast Injuries; Cell Death; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Disease Models, Animal; Disks Large Homolog 4 Protein; Gene Expression Regulation; Glycine; Guanylate Kinases; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Membrane Proteins; Papaverine; Phosphodiesterase 4 Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Time Factors

2017
In Silico, Ex Vivo and In Vivo Studies of Roflumilast as a Potential Antidiarrheal and Antispasmodic agent: Inhibition of the PDE-4 Enzyme and Voltage-gated Ca++ ion Channels.
    Molecules (Basel, Switzerland), 2020, Feb-24, Volume: 25, Issue:4

    Topics: Aminopyridines; Animals; Antidiarrheals; Benzamides; Binding Sites; Calcium Channel Blockers; Carbachol; Castor Oil; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Diarrhea; Isoproterenol; Jejunum; Mice; Molecular Docking Simulation; Papaverine; Parasympatholytics; Phosphodiesterase 4 Inhibitors; Protein Binding; Protein Interaction Domains and Motifs; Protein Structure, Secondary; Rabbits; Verapamil

2020